Atlas Arteria Stock Price, News & Analysis (OTCMKTS:MAQAF) $3.60 0.00 (0.00%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$3.60▼$3.6050-Day Range$3.27▼$3.9452-Week Range$3.25▼$5.01VolumeN/AAverage Volume2,177 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield2.31%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest About Atlas Arteria Stock (OTCMKTS:MAQAF)Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 13.4% interest in 22-kilometer toll road investors partnership II (TRIP II), the concessionaire for Dulles Greenway toll road located in Virginia, the United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia.Read More MAQAF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MAQAF Stock News HeadlinesDecember 7, 2023 | americanbankingnews.comAtlas Arteria (OTCMKTS:MAQAF) Trading Up 0.3%November 8, 2023 | morningstar.comAtlas Arteria Ltd MAQAFDecember 10, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 7, 2023 | afr.comIFM Investors creeps up Atlas Arteria’s register; Jarden on ticketOctober 3, 2023 | markets.businessinsider.comAtlas Arteria (MAQAF) Receives a Hold from RBC CapitalSeptember 27, 2023 | afr.comAtlas Arteria to fight new French motorway taxesSeptember 26, 2023 | finance.yahoo.comBullish Atlas Arteria Insiders Loaded Up On AU$1.3m Of StockSeptember 7, 2023 | finance.yahoo.comMAQAF - Atlas Arteria LimitedDecember 10, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comSeptember 1, 2023 | markets.businessinsider.comRBC Capital Sticks to Its Hold Rating for Atlas Arteria (MAQAF)July 4, 2023 | markets.businessinsider.comRBC Capital Sticks to Their Hold Rating for Atlas Arteria (MAQAF)June 17, 2023 | finance.yahoo.comWith 80% ownership of the shares, Atlas Arteria Limited (ASX:ALX) is heavily dominated by institutional ownersMay 30, 2023 | afr.com$9b tollroads group Atlas Arteria hit with first strikeMay 3, 2023 | afr.comIFM Investors creeps up at Atlas Arteria, Jarden trades $197m lineFebruary 27, 2023 | markets.businessinsider.comRBC Capital Reaffirms Their Buy Rating on Atlas Arteria (MAQAF)February 24, 2023 | finance.yahoo.comAtlas Arteria Full Year 2022 Earnings: Misses ExpectationsFebruary 23, 2023 | afr.comAtlas Arteria to bypass EastLink saleFebruary 22, 2023 | afr.comAtlas Arteria’s annual profits jump 47pc on traffic reboundJanuary 29, 2023 | markets.businessinsider.comABN Amro Reaffirms Their Hold Rating on Atlas Arteria (MAQAF)January 7, 2023 | finance.yahoo.comWith 81% ownership of the shares, Atlas Arteria Limited (ASX:ALX) is heavily dominated by institutional ownersDecember 19, 2022 | afr.comIFM adviser Ken Daley to join Atlas Arteria boardNovember 24, 2022 | markets.businessinsider.comPositive Report for Atlas Arteria (MAQAF) from RBC CapitalOctober 16, 2022 | afr.comAtlas Arteria stock back in play after $3b equity raiseOctober 2, 2022 | finance.yahoo.comMultiple insiders bought Atlas Arteria Limited (ASX:ALX) stock earlier this year, a positive sign for shareholdersSeptember 30, 2022 | afr.comAtlas Arteria share price sinks after $3.1b capital raisingSeptember 26, 2022 | afr.comIFM Investors’ war on Atlas Arteria gets personalSeptember 16, 2022 | fool.com.auWhy Atlas Arteria, Liontown, St Barbara, and Zip shares are dropping todaySee More Headlines Receive MAQAF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Atlas Arteria and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Infrastructure Operations Sub-IndustryN/A SectorIndustrials Current SymbolOTCMKTS:MAQAF CUSIPN/A CIKN/A Webwww.atlasarteria.com Phone611800621694FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Graeme Francis Bevans (Age 65)MD, CEO & Executive Director Comp: $2.05MMr. David CollinsChief Financial OfficerMr. Vincent Portal-BarraultChief Operating OfficerTess PalmerDirector of Investor RelationsMr. Clayton John McCormack B.Com.L.L.B., Company Secretary & General CounselNavleen PrasadPublic Affairs ManagerJim DicksonCorporate Development & Strategy ExecutiveMs. Catherine BrainGroup Executive of People & CultureMr. Paul Lynch B.Com.L.L.B., Joint Company SecretaryMr. Ryan Reynolds C.F.A.Specialist of Forecasting and AnalysisMore ExecutivesKey CompetitorsFerrovialOTCMKTS:FERVFPARK24OTCMKTS:PKCOYTransurban GroupOTCMKTS:TRAUFZhejiang ExpresswayOTCMKTS:ZHEXF2020 BulkersOTC:TTBKFView All Competitors MAQAF Stock Analysis - Frequently Asked Questions Should I buy or sell Atlas Arteria stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Atlas Arteria in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MAQAF shares. View MAQAF analyst ratings or view top-rated stocks. How have MAQAF shares performed in 2023? Atlas Arteria's stock was trading at $4.24 at the beginning of 2023. Since then, MAQAF shares have decreased by 15.1% and is now trading at $3.60. View the best growth stocks for 2023 here. Are investors shorting Atlas Arteria? Atlas Arteria saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 2,043,400 shares, an increase of 26.8% from the October 15th total of 1,611,700 shares. Based on an average daily volume of 2,300 shares, the days-to-cover ratio is currently 888.4 days. View Atlas Arteria's Short Interest. Is Atlas Arteria a good dividend stock? Atlas Arteria (OTCMKTS:MAQAF) pays an annual dividend of $0.08 per share and currently has a dividend yield of 5.02%. MAQAF has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. How do I buy shares of Atlas Arteria? Shares of MAQAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:MAQAF) was last updated on 12/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atlas Arteria Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.